retatrutides ESC 2024: Retatrutide improves lipid and cardiovascular risk profile in Phase II trial Retatrutide and Exercise: Maximizing Body
Description
Patients who are using GLP-1 drugs need to be sure that theyre continuing to eat nutritious, well-balanced diets
In terms of efficacy, tirzepatide is more effective than semaglutide in the field of weight loss
The glucagon activation increases energy expenditure, which is why retatrutide produces more weight loss
Sodium, potassium, and magnesium losses through sweat compound the depletion from reduced food intake
